Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of proinflammatory molecules in mice

Anastasia Kotanidou, Angeliki Xagorari, Eleni Bagli, Panagiota Kitsanta, Theodore Fotsis, Andreas Papapetropoulos, Charis Roussos

Research output: Contribution to journalArticle

123 Citations (Scopus)

Abstract

Luteolin is a flavonoid that has been shown to reduce proinflammatory molecule expression in vitro. In the present study, we have tested the ability of luteolin to inhibit lipopolysaccharide (LPS)-induced lethal toxicity and proinflammatory molecule expression in vivo. Mice receiving LPS (Salmonella enteriditis LPS, 32 mg/kg, intraperitoneally) exhibited high mortality with only 4.1% of the animals surviving seven days after the LPS challenge. On the contrary, mice that had received luteolin (0.2 mg/kg, intraperitoneally) before LPS showed an increased survival rate with 48% remaining alive on Day 7. To investigate the mechanism by which luteolin affords protection against LPS toxicity we measured intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor-α (TNF-α) production in response to LPS in the presence or absence of luteolin pretreatment. Treatment of animals with LPS increased serum TNF-α levels in a time-dependent manner. The increase in peak serum TNF-α levels was sensitive to luteolin pretreatment. Luteolin pretreatment also reduced LPS-stimulated ICAM-1 expression in the liver and abolished leukocyte infiltration in the liver and lung. We conclude that luteolin protects against LPS-induced lethal toxicity, possibly by inhibiting proinflammatory molecule (TNF-α ICAM-1) expression in vivo and reducing leukocyte infiltration in tissues.

Original languageEnglish (US)
Pages (from-to)818-823
Number of pages6
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume165
Issue number6
DOIs
StatePublished - Mar 15 2002
Externally publishedYes

Fingerprint

Luteolin
Lipopolysaccharides
Intercellular Adhesion Molecule-1
Tumor Necrosis Factor-alpha
Leukocytes
Liver
Serum
Flavonoids
Salmonella
Survival Rate

Keywords

  • Intercellular adhesion molecule
  • Lipopolysaccharide
  • Luteolin
  • Sepsis
  • Tumor necrosis factor-α

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of proinflammatory molecules in mice. / Kotanidou, Anastasia; Xagorari, Angeliki; Bagli, Eleni; Kitsanta, Panagiota; Fotsis, Theodore; Papapetropoulos, Andreas; Roussos, Charis.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 165, No. 6, 15.03.2002, p. 818-823.

Research output: Contribution to journalArticle

Kotanidou, Anastasia ; Xagorari, Angeliki ; Bagli, Eleni ; Kitsanta, Panagiota ; Fotsis, Theodore ; Papapetropoulos, Andreas ; Roussos, Charis. / Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of proinflammatory molecules in mice. In: American Journal of Respiratory and Critical Care Medicine. 2002 ; Vol. 165, No. 6. pp. 818-823.
@article{b0b09ccb2e064abba51f5ae6d331fc5d,
title = "Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of proinflammatory molecules in mice",
abstract = "Luteolin is a flavonoid that has been shown to reduce proinflammatory molecule expression in vitro. In the present study, we have tested the ability of luteolin to inhibit lipopolysaccharide (LPS)-induced lethal toxicity and proinflammatory molecule expression in vivo. Mice receiving LPS (Salmonella enteriditis LPS, 32 mg/kg, intraperitoneally) exhibited high mortality with only 4.1{\%} of the animals surviving seven days after the LPS challenge. On the contrary, mice that had received luteolin (0.2 mg/kg, intraperitoneally) before LPS showed an increased survival rate with 48{\%} remaining alive on Day 7. To investigate the mechanism by which luteolin affords protection against LPS toxicity we measured intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor-α (TNF-α) production in response to LPS in the presence or absence of luteolin pretreatment. Treatment of animals with LPS increased serum TNF-α levels in a time-dependent manner. The increase in peak serum TNF-α levels was sensitive to luteolin pretreatment. Luteolin pretreatment also reduced LPS-stimulated ICAM-1 expression in the liver and abolished leukocyte infiltration in the liver and lung. We conclude that luteolin protects against LPS-induced lethal toxicity, possibly by inhibiting proinflammatory molecule (TNF-α ICAM-1) expression in vivo and reducing leukocyte infiltration in tissues.",
keywords = "Intercellular adhesion molecule, Lipopolysaccharide, Luteolin, Sepsis, Tumor necrosis factor-α",
author = "Anastasia Kotanidou and Angeliki Xagorari and Eleni Bagli and Panagiota Kitsanta and Theodore Fotsis and Andreas Papapetropoulos and Charis Roussos",
year = "2002",
month = "3",
day = "15",
doi = "10.1164/ajrccm.165.6.2101049",
language = "English (US)",
volume = "165",
pages = "818--823",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "6",

}

TY - JOUR

T1 - Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of proinflammatory molecules in mice

AU - Kotanidou, Anastasia

AU - Xagorari, Angeliki

AU - Bagli, Eleni

AU - Kitsanta, Panagiota

AU - Fotsis, Theodore

AU - Papapetropoulos, Andreas

AU - Roussos, Charis

PY - 2002/3/15

Y1 - 2002/3/15

N2 - Luteolin is a flavonoid that has been shown to reduce proinflammatory molecule expression in vitro. In the present study, we have tested the ability of luteolin to inhibit lipopolysaccharide (LPS)-induced lethal toxicity and proinflammatory molecule expression in vivo. Mice receiving LPS (Salmonella enteriditis LPS, 32 mg/kg, intraperitoneally) exhibited high mortality with only 4.1% of the animals surviving seven days after the LPS challenge. On the contrary, mice that had received luteolin (0.2 mg/kg, intraperitoneally) before LPS showed an increased survival rate with 48% remaining alive on Day 7. To investigate the mechanism by which luteolin affords protection against LPS toxicity we measured intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor-α (TNF-α) production in response to LPS in the presence or absence of luteolin pretreatment. Treatment of animals with LPS increased serum TNF-α levels in a time-dependent manner. The increase in peak serum TNF-α levels was sensitive to luteolin pretreatment. Luteolin pretreatment also reduced LPS-stimulated ICAM-1 expression in the liver and abolished leukocyte infiltration in the liver and lung. We conclude that luteolin protects against LPS-induced lethal toxicity, possibly by inhibiting proinflammatory molecule (TNF-α ICAM-1) expression in vivo and reducing leukocyte infiltration in tissues.

AB - Luteolin is a flavonoid that has been shown to reduce proinflammatory molecule expression in vitro. In the present study, we have tested the ability of luteolin to inhibit lipopolysaccharide (LPS)-induced lethal toxicity and proinflammatory molecule expression in vivo. Mice receiving LPS (Salmonella enteriditis LPS, 32 mg/kg, intraperitoneally) exhibited high mortality with only 4.1% of the animals surviving seven days after the LPS challenge. On the contrary, mice that had received luteolin (0.2 mg/kg, intraperitoneally) before LPS showed an increased survival rate with 48% remaining alive on Day 7. To investigate the mechanism by which luteolin affords protection against LPS toxicity we measured intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor-α (TNF-α) production in response to LPS in the presence or absence of luteolin pretreatment. Treatment of animals with LPS increased serum TNF-α levels in a time-dependent manner. The increase in peak serum TNF-α levels was sensitive to luteolin pretreatment. Luteolin pretreatment also reduced LPS-stimulated ICAM-1 expression in the liver and abolished leukocyte infiltration in the liver and lung. We conclude that luteolin protects against LPS-induced lethal toxicity, possibly by inhibiting proinflammatory molecule (TNF-α ICAM-1) expression in vivo and reducing leukocyte infiltration in tissues.

KW - Intercellular adhesion molecule

KW - Lipopolysaccharide

KW - Luteolin

KW - Sepsis

KW - Tumor necrosis factor-α

UR - http://www.scopus.com/inward/record.url?scp=0037086366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037086366&partnerID=8YFLogxK

U2 - 10.1164/ajrccm.165.6.2101049

DO - 10.1164/ajrccm.165.6.2101049

M3 - Article

VL - 165

SP - 818

EP - 823

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 6

ER -